Nuvo Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This report of Nuvo Pharmaceuticals Inc leverages data points from across the internet as well as from public documents by Nuvo Pharmaceuticals Inc. Other companies in the scoring peer group for Nuvo Pharmaceuticals Inc are displayed below. If you are employed by Nuvo Pharmaceuticals Inc and you wish to licence your ESG rating, please get in touch.
Nuvo Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 8.0, social score of 2.7 and governance score of 2.7.
4.5
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
852 | Vaccibody AS | 4.6 | High |
852 | argenx SE | 4.6 | High |
868 | Nuvo Pharmaceuticals Inc | 4.5 | High |
868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
868 | Boiron SA | 4.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Nuvo Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Nuvo Pharmaceuticals Inc disclose current and historical energy intensity?
Does Nuvo Pharmaceuticals Inc report the average age of the workforce?
Does Nuvo Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Nuvo Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Nuvo Pharmaceuticals Inc disclose cybersecurity risks?
Does Nuvo Pharmaceuticals Inc offer flexible work?
Does Nuvo Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Nuvo Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Nuvo Pharmaceuticals Inc conduct supply chain audits?
Does Nuvo Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Nuvo Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Nuvo Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Nuvo Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Nuvo Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Nuvo Pharmaceuticals Inc disclose water use targets?
Does Nuvo Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Nuvo Pharmaceuticals Inc have a product recall in the last two years?
Does Nuvo Pharmaceuticals Inc disclose incidents of discrimination?
Does Nuvo Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Nuvo Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Nuvo Pharmaceuticals Inc disclose parental leave metrics?
Does Nuvo Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Nuvo Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Nuvo Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Nuvo Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Nuvo Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Nuvo Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Nuvo Pharmaceuticals Inc involved in embryonic stem cell research?
Does Nuvo Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Nuvo Pharmaceuticals Inc disclose its waste policy?
Does Nuvo Pharmaceuticals Inc report according to TCFD requirements?
Does Nuvo Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Nuvo Pharmaceuticals Inc disclose energy use targets?
Does Nuvo Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Nuvo Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Nuvo Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet, a migraine medicine; NeoVisc, an injectable viscosupplement for osteoarthritis; and Resultz, FullMarks, and LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA and RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was incorporated in 1983 and is headquartered in Mississauga, Canada.